OPERA · WA21093
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A randomized, double-blind, double-dummy, parallel-group study to evaluate the efficacy and safety of ocrelizumab compared with interferon beta-1a (Rebif®) in patients with relapsing multiple sclerosis. EudraCT: 2010-020315-36
Sponsor: ROCHE
Phase: III
Area: Neuroimmunology